Wang N, Zou J, Li S, Deng X, Zeng J, Ding C
    
    
    BMC Ophthalmol. 2024; 24(1):354.
  
  
    PMID: 39164640
    
          PMC: 11334535.
    
          DOI: 10.1186/s12886-024-03619-y.
      
 
                                  
  
    Allingham M, Loksztejn A, Cousins S, Mettu P
    
    
    Adv Exp Med Biol. 2021; 1256:143-189.
  
  
    PMID: 33848001
    
    
          DOI: 10.1007/978-3-030-66014-7_6.
      
 
                                  
  
    Mettu P, Allingham M, Cousins S
    
    
    Prog Retin Eye Res. 2020; 82:100906.
  
  
    PMID: 33022379
    
          PMC: 10368393.
    
          DOI: 10.1016/j.preteyeres.2020.100906.
      
 
                                  
  
    Rajavi Z, Safi S, Javadi M, Azarmina M, Moradian S, Entezari M
    
    
    J Ophthalmic Vis Res. 2016; 11(4):394-414.
  
  
    PMID: 27994809
    
          PMC: 5139552.
    
          DOI: 10.4103/2008-322X.194131.
      
 
                                  
  
    Takata S, Masuda T, Nakamura S, Kuchimaru T, Tsuruma K, Shimazawa M
    
    
    Sci Rep. 2015; 5:9898.
  
  
    PMID: 25927172
    
          PMC: 4415651.
    
          DOI: 10.1038/srep09898.
      
 
                              
              
                              
                                      
  Choroidal Neovascularization Induces Retinal Edema and its Treatment Addresses this Problem.
  
    Tadayoni R
    
    
    J Ophthalmic Vis Res. 2015; 9(4):405-6.
  
  
    PMID: 25709762
    
          PMC: 4329697.
    
          DOI: 10.4103/2008-322X.150799.
      
 
                                          
                                                          
  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).
  
    Kuppermann B, Zacharias L, Kenney M
    
    
    Trans Am Ophthalmol Soc. 2015; 112:116-41.
  
  
    PMID: 25646032
    
          PMC: 4311675.
    
      
 
                                          
                                                          
  Animal models of age related macular degeneration.
  
    Pennesi M, Neuringer M, Courtney R
    
    
    Mol Aspects Med. 2012; 33(4):487-509.
  
  
    PMID: 22705444
    
          PMC: 3770531.
    
          DOI: 10.1016/j.mam.2012.06.003.
      
 
                                          
                                                          
  Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.
  
    Sivak J, Ostriker A, Woolfenden A, Demirs J, Cepeda R, Long D
    
    
    J Biol Chem. 2011; 286(52):44965-75.
  
  
    PMID: 22072717
    
          PMC: 3248015.
    
          DOI: 10.1074/jbc.M111.294967.
      
 
                                          
                                                          
  Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature.
  
    Brouzas D, Charakidas A, Rotsos T, Moschos M, Loukianou H, Koutsandrea C
    
    
    Clin Ophthalmol. 2010; 4:871-6.
  
  
    PMID: 20714365
    
          PMC: 2921295.
    
          DOI: 10.2147/opth.s10394.
      
 
                                          
                                                          
  Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor.
  
    Sassa Y, Hata Y
    
    
    Clin Ophthalmol. 2010; 4:275-83.
  
  
    PMID: 20463795
    
          PMC: 2861934.
    
          DOI: 10.2147/opth.s6448.
      
 
                                          
                                                          
  Treatment of neovascular age-related macular degeneration: Current therapies.
  
    Augustin A, Scholl S, Kirchhof J
    
    
    Clin Ophthalmol. 2009; 3:175-82.
  
  
    PMID: 19668562
    
          PMC: 2708986.
    
          DOI: 10.2147/opth.s3926.
      
 
                                          
                                                          
  Visualizing vitreous in vitrectomy by triamcinolone.
  
    Sakamoto T, Ishibashi T
    
    
    Graefes Arch Clin Exp Ophthalmol. 2009; 247(9):1153-63.
  
  
    PMID: 19543906
    
    
          DOI: 10.1007/s00417-009-1118-2.
      
 
                                          
                                                          
  Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.
  
    Nakao S, Hata Y, Miura M, Noda K, Kimura Y, Kawahara S
    
    
    Am J Pathol. 2007; 171(3):1058-65.
  
  
    PMID: 17690185
    
          PMC: 1959485.
    
          DOI: 10.2353/ajpath.2007.070172.
      
 
                                          
                                                          
  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
  
    Chan W, Lai T, Wong A, Liu D, Lam D
    
    
    Br J Ophthalmol. 2006; 91(2):174-9.
  
  
    PMID: 16987898
    
          PMC: 1857631.
    
          DOI: 10.1136/bjo.2006.103606.
      
 
                                          
                                                          
  A preliminary benefit-risk assessment of verteporfin in age-related macular degeneration.
  
    Wickens J, Blinder K
    
    
    Drug Saf. 2006; 29(3):189-99.
  
  
    PMID: 16524319
    
    
          DOI: 10.2165/00002018-200629030-00003.
      
 
                                          
                                                          
  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
  
    Chan W, Lai T, Wong A, Tong J, Liu D, Lam D
    
    
    Br J Ophthalmol. 2006; 90(3):337-41.
  
  
    PMID: 16488958
    
          PMC: 1856972.
    
          DOI: 10.1136/bjo.2005.081299.
      
 
                                          
                                                          
  Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].
  
    Agurto-Rivera R, Diaz-Rubio J, Torres-Bernal L, Macky T, Colina-Luquez J, Papa-Oliva G
    
    
    BMC Ophthalmol. 2005; 5:27.
  
  
    PMID: 16309554
    
          PMC: 1314893.
    
          DOI: 10.1186/1471-2415-5-27.
      
 
                                          
                                                          
  Choroidal neovascularisation in pathological myopia: an update in management.
  
    Chan W, Ohji M, Lai T, Liu D, Tano Y, Lam D
    
    
    Br J Ophthalmol. 2005; 89(11):1522-8.
  
  
    PMID: 16234465
    
          PMC: 1772951.
    
          DOI: 10.1136/bjo.2005.074716.
      
 
                                          
                                                          
  Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
  
    Murata M, Shimizu S, Horiuchi S, Taira M
    
    
    Graefes Arch Clin Exp Ophthalmol. 2005; 244(2):205-9.
  
  
    PMID: 16044325
    
    
          DOI: 10.1007/s00417-005-0036-1.